[Next-Generation Sequencing Book]
  • [Photo] Gary Van Domselaar • March 20, 2001
    ``Biotechnology company Oxford Glycosciences is hoping to apply for patents over 4,000 proteins by the end of the year, as part of a `land grab' to corner the rights to promising areas of research.

    ``The firm, which yesterday announced a 62% jump in full-year losses to £16.8m, sells information about proteins to other drugs companies.

    ``It has already made applications covering 1,500 proteins which it believes to be associated with disease. Chief executive Michael Kranda said: `We're focusing on land grab proteomics. We're really in a very good position to attack this technology.'

    ``Proteins are governed by genes in the body, and their activity is central to the maintenance of good health. Some biotechnology companies are targeting genes in the race to create new medicines but the completion of the Human Genome Project revealed that there are only about 30,000 genes in the body, rather than the expected 150,000.

    ``As a result, Mr Kranda said proteins are becoming the new battleground: `There are 300,000 to 500,000 proteins out there. The value is really going to be in understanding the protein world.'''

    Full story:
    http://www.guardian.co.uk/Archive/Article/0,4273,4153180,00.html

    Reference by Snowdeal.org.

Discussion forums: Guardian: Glycosciences Makes `Land Grab' for Proteins

Expanded view | Monitor forum | Save place

Start a new thread:

You have to be logged in to post a reply.

© 1998-2025 Scilico, LLC. All rights reserved.